Luis Alfredo Wadskier Gutiérrez
Research Subjects
Luis Alfredo Wadskier Gutiérrez has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Marcela Arias Salazar
Colombian Urology Research Group (CURG) Barranquilla Colombia
1 shared publication Clayton Trimmer
Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas
1 shared publication- Daniel Mauricio Colmenares Leal
Colombian Urology Research Group (CURG) Barranquilla Colombia
1 shared publication - Giovanni Enrico Cacciamani
USC Institute of Urology, University of Southern California, Los Angeles, USA
1 shared publication Heilen P Bravo
Universidad Cooperativa de Colombia, Facultad de Medicina, Departamento de Investigación -GRIVI, Villavicencio, Colombia
1 shared publication- Isabella Morales García
Colombian Urology Research Group (CURG) Barranquilla Colombia
1 shared publication
Latest Publications
- 13 October 2026
- Published by Wiley in Neurourology and Urodynamics
Standing or Sitting to Void? Comparative Uroflowmetry in Healthy Male Volunteers: A Randomized Crossover Study with Equivalence Analysis
Introduction: The posture adopted during voiding may influence uroflowmetric parameters, such as maximum urinary flow rate (Qmax), voided volume, and time to maximum flow (tQmax). Published studies have shown inconsistent results, and uncertainty persists regarding the clinical relevance of these differences in healthy men. Objective: To compare uroflowmetric parameters during standing and sitting voiding in healthy male volunteers using a randomized crossover design, incorporating a formal equivalence analysis (Two One‐Sided Tests, TOST) for the primary outcome (Qmax). Material and Methods: This prospective, randomized, 2 × 2 crossover study included 52 healthy male volunteers allocated to the sitting → standing ( n = 24) or standing → sitting ( n = 28) sequence, with a minimum washout period of 24 h. The primary outcome was Qmax and the secondary outcomes were the total voided volume and tQmax. Paired tests, correction for multiple comparisons (Bonferroni and Benjamini‐Hochberg), linear mixed‐effects models, Bayesian analysis, and TOST equivalence analysis for Qmax (margin ±2.5 mL/s) were used. Results: Baseline characteristics were comparable between sequences. No significant differences between postures were observed for Qmax (Δ = −1.47 mL/s; 95% CI −3.55 to 0.62; p = 0.164) or for total volume (Δ = −14.7 mL; 95% CI −43.9 to 14.6; p = 0.318). The tQmax was longer while standing (Δ = +3.32 s; 95% CI 0.94 to 5.69; p = 0.011), remaining significant after Bonferroni correction ( p = 0.031) and FDR correction ( q = 0.031). The mixed models did not identify either sequence or period effects. Bayesian analysis showed moderate evidence in favor of a difference in tQmax (BF 10 = 4.99) and in favor of no difference in volume (BF 01 = 4.10). The equivalence analysis (TOST) for Qmax was not significant (p‐TOST ≈ 0.16); therefore, the equivalence of the maximum flow between postures could not be formally claimed with the present sample size. Conclusions: In healthy men, voiding posture did not significantly modify the maximum urinary flow rate or voided volume; however, formal equivalence of Qmax was not demonstrated. The sitting position was associated with a shorter time to maximum flow, a small difference that is unlikely to be clinically meaningful and was partly dependent on a single outlier. Larger, pre‐registered studies with pre‐specified equivalence analyses and symptomatic populations are required.
- 13 October 2026
- Published by Wiley in Neurourology and Urodynamics
Standing or Sitting to Void? Comparative Uroflowmetry in Healthy Male Volunteers: A Randomized Crossover Study with Equivalence Analysis
Introduction: The posture adopted during voiding may influence uroflowmetric parameters, such as maximum urinary flow rate (Qmax), voided volume, and time to maximum flow (tQmax). Published studies have shown inconsistent results, and uncertainty persists regarding the clinical relevance of these differences in healthy men. Objective: To compare uroflowmetric parameters during standing and sitting voiding in healthy male volunteers using a randomized crossover design, incorporating a formal equivalence analysis (Two One‐Sided Tests, TOST) for the primary outcome (Qmax). Material and Methods: This prospective, randomized, 2 × 2 crossover study included 52 healthy male volunteers allocated to the sitting → standing ( n = 24) or standing → sitting ( n = 28) sequence, with a minimum washout period of 24 h. The primary outcome was Qmax and the secondary outcomes were the total voided volume and tQmax. Paired tests, correction for multiple comparisons (Bonferroni and Benjamini‐Hochberg), linear mixed‐effects models, Bayesian analysis, and TOST equivalence analysis for Qmax (margin ±2.5 mL/s) were used. Results: Baseline characteristics were comparable between sequences. No significant differences between postures were observed for Qmax (Δ = −1.47 mL/s; 95% CI −3.55 to 0.62; p = 0.164) or for total volume (Δ = −14.7 mL; 95% CI −43.9 to 14.6; p = 0.318). The tQmax was longer while standing (Δ = +3.32 s; 95% CI 0.94 to 5.69; p = 0.011), remaining significant after Bonferroni correction ( p = 0.031) and FDR correction ( q = 0.031). The mixed models did not identify either sequence or period effects. Bayesian analysis showed moderate evidence in favor of a difference in tQmax (BF 10 = 4.99) and in favor of no difference in volume (BF 01 = 4.10). The equivalence analysis (TOST) for Qmax was not significant (p‐TOST ≈ 0.16); therefore, the equivalence of the maximum flow between postures could not be formally claimed with the present sample size. Conclusions: In healthy men, voiding posture did not significantly modify the maximum urinary flow rate or voided volume; however, formal equivalence of Qmax was not demonstrated. The sitting position was associated with a shorter time to maximum flow, a small difference that is unlikely to be clinically meaningful and was partly dependent on a single outlier. Larger, pre‐registered studies with pre‐specified equivalence analyses and symptomatic populations are required.
- Open Access
- 12 December 2017
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 11, 789
Primary non-Hodgkin lymphoma of the prostate: a case report
Ecancermedicalscience is the peer-reviewed open access cancer journal founded by the European Institute of Oncology in Milan. We consider articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epide
- 12 December 2017
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 11, 789
Open AccessPrimary non-Hodgkin lymphoma of the prostate: a case report
Ecancermedicalscience is the peer-reviewed open access cancer journal founded by the European Institute of Oncology in Milan. We consider articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epide
- 1 December 2013
- Published by SAGE Publications in Journal of Endourology
- Vol. 27 (12) , 1516-1519
Renal Function Outcomes Following Selective Angioembolization for Iatrogenic Vascular Lesions After Partial Nephrectomy
To report one of the largest series of clinical and renal function outcomes of treated iatrogenic vascular lesions (IVL) after partial nephrectomy (PN). Angioembolization (AE) is the treatment of choice for patients with these lesions, but the additional renal injury conferred by this treatment has not been well described. Patients who underwent open, laparoscopic, or robot-assisted PN from 2002 to 2012 were identified and those with AE were selected. Patients' charts were reviewed, and renal function was analyzed using estimated glomerular filtration rate (eGFR) and progression of chronic kidney disease (CKD) classification before and after PN and AE. There were 849 patients who underwent PN and an IVL developed in 28 (3.3%). Twenty (71%) presented with gross hematuria at a mean of 10.2 ± 7.7 days after PN and 8 (28%) needed transfusion. All patients had identifiable IVL at the time of selective AE, and technical success was achieved in 24/28 (86%), although 4 needed subsequent additional AE. The paired decrease in eGFR after PN was significant (P<0.01), while the paired change in eGFR after AE was not with either short-term (2.8 days) or intermediate-term (362 days) follow-up (P=0.50). Four patients experienced transient worsening in CKD classification after AE, although three experienced CKD stage improvement. Selective AE for IVL after PN is safe, efficacious, and does not lead to a significant impairment of renal function. It remains the preferred approach for the evaluation and management of post-PN hemorrhage.
- 1 December 2013
- Published by SAGE Publications in Journal of Endourology
- Vol. 27 (12) , 1516-1519
Renal Function Outcomes Following Selective Angioembolization for Iatrogenic Vascular Lesions After Partial Nephrectomy
To report one of the largest series of clinical and renal function outcomes of treated iatrogenic vascular lesions (IVL) after partial nephrectomy (PN). Angioembolization (AE) is the treatment of choice for patients with these lesions, but the additional renal injury conferred by this treatment has not been well described. Patients who underwent open, laparoscopic, or robot-assisted PN from 2002 to 2012 were identified and those with AE were selected. Patients' charts were reviewed, and renal function was analyzed using estimated glomerular filtration rate (eGFR) and progression of chronic kidney disease (CKD) classification before and after PN and AE. There were 849 patients who underwent PN and an IVL developed in 28 (3.3%). Twenty (71%) presented with gross hematuria at a mean of 10.2 ± 7.7 days after PN and 8 (28%) needed transfusion. All patients had identifiable IVL at the time of selective AE, and technical success was achieved in 24/28 (86%), although 4 needed subsequent additional AE. The paired decrease in eGFR after PN was significant (P<0.01), while the paired change in eGFR after AE was not with either short-term (2.8 days) or intermediate-term (362 days) follow-up (P=0.50). Four patients experienced transient worsening in CKD classification after AE, although three experienced CKD stage improvement. Selective AE for IVL after PN is safe, efficacious, and does not lead to a significant impairment of renal function. It remains the preferred approach for the evaluation and management of post-PN hemorrhage.